Stephen H. Kazakoff

Biochemistry, Genetics and Molecular Biology · Life Sciences

50h-index27.8kcitations202works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(53), Melanoma and MAPK Pathways(24), Epigenetics and DNA Methylation(21), Genetic factors in colorectal cancer(18), Computational Drug Discovery Methods(17)

Publications153 total

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Cancer Cell·2025· 1 cited
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
EBioMedicine·2024· 1 citedOpen Access
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in early-stage follicular lymphoma: TROG99.03
2024Open Access
Integrative temporal multi-omics reveals uncoupling of transcriptome and proteome during human T cell activation
npj Systems Biology and Applications·2024· 13 citedOpen Access
Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Samples from Advanced Non-Small Cell Lung Cancer for Whole Genome, Whole Exome and Comprehensive Panel Sequencing
Cancers·2024· 3 citedOpen Access
High Frequency of HLA-Class II B Cell Receptor Neoantigens in IGHV Mutated-CLL
Blood·2023· 1 cited
Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report
Frontiers in Oncology·2023· 1 citedOpen Access
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer
Nature Cancer·2023· 110 citedOpen Access
Prognostic impact of HLA‐I neoantigen‐specific CD8+ T cells in limited‐stage follicular lymphoma
Hematological Oncology·2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Nicola Waddell(41), John V. Pearson(38), Kátia Nones(31), Ann‐Marie Patch(29), Conrad Leonard(27), Felicity Newell(27), Scott Wood(26), Oliver Holmes(24), Qinying Xu(16), Pamela Mukhopadhyay(14), Sean M. Grimmond(13), Peter J. Bailey(11), David K. Chang(11), Angelika N. Christ(11), Michael C. Quinn(11), Andrew P. Barbour(11), Amber L. Johns(10), Timothy J. C. Bruxner(10), Craig Nourse(10), Nick M. Waddell(10)